H3D Centre in Cape Town develops new malaria and tuberculosis drugs for Africa in 2024

The H3D Centre in South Africa is now testing new medicines for malaria and tuberculosis. This research is more focused on African health needs than previous global projects.
By Newsroom | Health, South Africa |

Holistic Drug Discovery and Development (H3D) Centre in South Africa is drawing attention for its work on medications for diseases prevalent on the continent. Led by Kelly Chibale, a scientist from Zambia, the facility at the University of Cape Town is reportedly undertaking "extraordinary" research.

The core of the operation appears to be a sustained effort to develop drugs addressing significant health issues such as malaria and tuberculosis. This focus highlights an intention to tackle ailments disproportionately affecting populations in Africa. The laboratory's endeavors are positioned as pivotal in reshaping the terrain of medical investigation within the region.

Chibale’s involvement is marked by a declared passion for chemistry, viewed not just as a scientific discipline but also as an artistic pursuit. This drive, according to reports, underpins the center's commitment to drug hunting, a process likened by Chibale to a "fairy-tale quest" that may involve unexpected breakthroughs.

The establishment of such a center in South Africa is framed as a critical move to build local capacity for addressing health challenges that have global implications. The work at the H3D Centre is described as groundbreaking, aiming for substantial outcomes through persistent research and development.

Read More: Pensacola Officer Charged for Not Telling Partner About HIV Before Pregnancy

Frequently Asked Questions

Q: What is the H3D Centre in Cape Town doing for malaria and tuberculosis patients?
The H3D Centre at the University of Cape Town is researching and creating new medicines specifically for malaria and tuberculosis. This work helps patients in Africa by focusing on diseases that affect the continent the most.
Q: Who is leading the drug research at the H3D Centre in South Africa?
The scientist Kelly Chibale from Zambia leads the team at the H3D Centre. He uses his passion for chemistry to find new ways to treat serious illnesses.
Q: Why is the H3D Centre research important for global health?
This center builds local capacity to solve health problems in Africa that have global importance. By creating drugs locally, the center helps reduce the reliance on international medicine supplies.
Q: How does the H3D Centre describe its process for finding new medicines?
Kelly Chibale describes the drug discovery process as a 'fairy-tale quest' that requires hard work and persistence. The team believes that this scientific approach will lead to important breakthroughs for patients.